Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

CAR-T Meeting 2025

The EHA-EBMT 7th European CAR T-cell Meeting

06–08 February 2025 | Strasbourg, France

Jointly organized by the EHA and EBMT, the 7th European CAR T-cell Meeting took place on February 6-8, 2025, in Strasbourg, France, and online, and covered the latest clinical and translational advances in CAR-T therapy.

View all videos

CAR-T in multiple myeloma: optimizing bridging therapy & moving CAR-T into earlier lines of therapy

Hermann Einsele • 10 Feb 2025

Novel CAR-T constructs on the horizon for multiple myeloma

Hermann Einsele • 10 Feb 2025

The efficacy of bispecific antibodies targeting BCMA or GPRC5D in relapsed myeloma after CAR-T

Nico Gagelmann • 7 Feb 2025

Treatment failure patterns in second-line versus third-line introduction of CAR-T therapy in LBCL

Roni Shouval • 7 Feb 2025

Results of the pivotal CART19-BE-02 trial, a multicenter trial of var-cel for adult R/R B-ALL

Valentín Ortiz-Maldonado • 7 Feb 2025

CAR-T in CLL: updates from the TRANSCEND-CLL-004 trial and when to choose CAR-T for these patients

Tanya Siddiqi • 7 Feb 2025

The current status of CAR T-cell therapy for lymphoma in the UK

Andrea Kuhnl • 7 Feb 2025

A European study investigating patient-reported outcomes of CAR T-cell therapy

Anne Spanjaart et al. • 7 Feb 2025